Massive Volume Lifts Johnson & Johnson
A trio of upgrades on Johnson & Johnson (JNJ) have sparked a massive wave of buying this morning. A day after the company received approval for its purchase of Synthes, JPMorgan raised the major drug manufacturer to Overweight. Positive comments from Raymond James and Jefferies have also added fuel to the fire.
The bullish news led to a huge gap-higher open that lifted the stock 1.5%. In the very early going, the stock filled a high-volume downside gap that it had left behind on May 14. This supply area, along with a declining 200-day moving average, held in well despite the extremely heavy accumulation. JNJ faded from this level and fell all the way back down to yesterday's settle, filling the giant opening gap in the process. At midday, the stock has stabilized near $63.50....184 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
